Prion Disease: Cholesterol

The Prion Disease: Cholesterol feed describes the role cholesterol plays in the conversion and transmission of prion. Discover the latest research on the role of cholesterol in prion disease here.

May 17, 2020
ReviewOpen Access

Understanding the Pathophysiology of Cerebral Amyloid Angiopathy

International Journal of Molecular Sciences
Laura GattiAnna Bersano
May 26, 2020

The HSP110/HSP70 disaggregation system generates spreading-competent toxic α-synuclein species

The EMBO Journal
Jessica TittelmeierCarmen Nussbaum-Krammer
May 28, 2020
Open Access

Mosaic Somatic Gene Recombination as a Potentially Unifying Hypothesis for Alzheimer's Disease

Frontiers in Genetics
Gwendolyn E Kaeser, Jerold Chun
May 11, 2020
Review

Prions: Roles in Development and Adaptive Evolution

Journal of Molecular Evolution
Jamie D Dixson, Rajeev K Azad
May 18, 2020

Soy flavonoids prevent cognitive deficits induced by intra-gastrointestinal administration of beta-amyloid

Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association
Julia Y H LiuJohn A Rudd
May 9, 2020

Molecular Mechanism for the Suppression of Alpha Synuclein Membrane Toxicity by an Unconventional Extracellular Chaperone

Journal of the American Chemical Society
Rashik AhmedGiuseppe Melacini
May 11, 2020

Distribution of TDP-43 Pathology in Hippocampal Synaptic Relays Suggests Transsynaptic Propagation in Frontotemporal Lobar Degeneration

Journal of Neuropathology and Experimental Neurology
Pouya JamshidiChangiz Geula
May 23, 2020
Review

Evidence of distinct α-synuclein strains underlying disease heterogeneity

Acta Neuropathologica
Sara A M Holec, Amanda L Woerman
May 10, 2020
Open Access

Intrinsic toxicity of the cellular prion protein is regulated by its conserved central region

FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
Graham P RosemanGlenn L Millhauser

Sign up to follow this feed and discover related papers.

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Age-related Dementia

Age-related dementia (Alzheimer's disease) results from the destructive impact of the pulse on cerebral vasculature. Evidence is reviewed that the neuropathology of the dementia is caused by the breakdown of small cerebral vessels (silent microbleeds), that the microbleeds result from pulse-induced damage to the cerebral vessels, and that pulse becomes increasingly destructive with age, because of the age-related stiffening of the aorta and great arteries, which causes an increase in the intensity of the pressure pulse. Discover the latest research on age-related dementia here.

© 2020 Meta ULC. All rights reserved
/feed-previews/prion-disease-cholesterol/e64c4078-4fb1-4987-ae48-b344ed33e45d